VTAMA® (tapinarof) cream, 1% HCP

👥 1 employees💰 Last funded Mar 2019
Welcome to the official VTAMA® (tapinarof) cream, 1% LinkedIn page. This product information is intended for US Healthcare Professionals only. Please see full Important Safety Information in the pinned post and at https://www.vtama.com/hcp/. Please see the full Prescribing Information including Patient Information by visiting https://www.vtama.com/hcp/PI. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. © 2023 Dermavant Sciences, Inc. All Rights Reserved. All trademarks are the property of Dermavant Sciences, GmbH.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in VTAMA® (tapinarof) cream, 1% HCP?
VTAMA® (tapinarof) cream, 1% HCP has 1 investors on record on gritt.io.
When did VTAMA® (tapinarof) cream, 1% HCP last raise funding?
The most recent investment in VTAMA® (tapinarof) cream, 1% HCP recorded on gritt.io was in March 2019.
What industry is VTAMA® (tapinarof) cream, 1% HCP in?
VTAMA® (tapinarof) cream, 1% HCP operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.